Troglitazone-induced intracellular oxidative stress in rat hepatoma cells: a flow cytometric assessment (Q40669220)

22 September 2017

Troglitazone-induced intracellular oxidative stress in rat hepatoma cells: a flow cytometric assessment (English)

1 reference

22 September 2017

1 reference

hepatocellular carcinoma

1 reference

inferred from title

author name string

Padma Kumar Narayanan

1

1 reference

22 September 2017

Timothy Hart

2

1 reference

22 September 2017

Fiona Elcock

3

1 reference

22 September 2017

Cindy Zhang

4

1 reference

22 September 2017

Laura Hahn

5

1 reference

22 September 2017

David McFarland

6

1 reference

22 September 2017

Lester Schwartz

7

1 reference

22 September 2017

D Gwyn Morgan

8

1 reference

22 September 2017

Peter Bugelski

9

1 reference

22 September 2017

1 March 2003

1 reference

22 September 2017

1 reference

22 September 2017

52

1 reference

22 September 2017

1

1 reference

22 September 2017

28-35

1 reference

The role of a mitochondrial pathway in the induction of apoptosis by chemicals extracted from diesel exhaust particles

22 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10011

Oxidants in mitochondria: from physiology to diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10011

Troglitazone-induced hepatic failure leading to liver transplantation. A case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10011

7 January 2021

In vitro studies on the action of CS-045, a new antidiabetic agent

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10011

7 January 2021

Studies on the metabolism of troglitazone to reactive intermediates in vitro and in vivo. Evidence for novel biotransformation pathways involving quinone methide formation and thiazolidinedione ring scission.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10011

7 January 2021

Enzyme-induction dependent bioactivation of troglitazone and troglitazone quinone in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10011

7 January 2021

The drug metabolism systems of liver and liver tumors: a comparison of activities and characteristics

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10011

7 January 2021

Drug metabolism in the Novikoff hepatoma: evidence for a mixed function oxidase system and partial purification of cytochrome P-450 reductase

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10011

7 January 2021

Oxidative metabolism in a rat hepatoma (N13) and isolated rat hepatocytes: a flow cytometric comparative study

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10011

7 January 2021

Novel fluorescein-based flow-cytometric method for detection of lipid peroxidation.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10011

7 January 2021

Critical evaluation of the use of hydroethidine as a measure of superoxide anion radical

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10011

7 January 2021

Intracellular hydrogen peroxide and superoxide anion detection in endothelial cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10011

7 January 2021

Detection of apoptosis and changes in mitochondrial membrane potential with chloromethyl-X-rosamine

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10011

7 January 2021

Inhibition of oxidation of low density lipoprotein by troglitazone

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10011

7 January 2021

In vitro inhibitory effects of troglitazone and its metabolites on drug oxidation activities of human cytochrome P450 enzymes: comparison with pioglitazone and rosiglitazone

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10011

7 January 2021

Molecular mechanisms of quinone cytotoxicity

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10011

7 January 2021

Cytotoxicity and apoptosis produced by troglitazone in human hepatoma cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10011

7 January 2021

Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10011

7 January 2021

Peroxisome proliferator-activated receptor-gamma-independent inhibition of macrophage activation by the non-thiazolidinedione agonist L-796,449. Comparison with the effects of 15-deoxy-delta(12,14)-prostaglandin J(2).

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10011

7 January 2021

Troglitazone inhibits fatty acid oxidation and esterification, and gluconeogenesis in isolated hepatocytes from starved rats.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10011

7 January 2021

Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-gamma

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10011

7 January 2021

Mitochondrial respiratory enzymes are a major target of iron toxicity in rat heart cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10011

7 January 2021

Diabetes increases the risk of acute hepatic failure

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10011

7 January 2021

Mitochondria in organismal aging and degeneration

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10011

7 January 2021

Identifiers

DOI

10.1002/CYTO.A.10011

1 reference

22 September 2017

1 reference